Keywords: fda, warning, letter, over, fialuridine, national, institutes

FDA WARNING LETTER OVER FIALURIDINE

Article | 23 May 1994

The National Institutes of Health, Eli Lilly and other scientists violated federal regulations during testing of fialuridine, an experimental hepatitis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lilly

Go to company listing